2005
DOI: 10.1038/modpathol.3800306
|View full text |Cite
|
Sign up to set email alerts
|

Origins and molecular pathology of ovarian cancer

Abstract: Epithelial ovarian cancer comprises the majority of malignant ovarian tumors in adult women. These neoplasms are classified into distinct morphologic categories based on the appearance of the epithelium into tumors of serous, mucinous, endometrioid, clear cell, transitional, squamous, mixed and undifferentiated type. Current data indicate that each of these histologic subtypes is associated with distinct morphologic and molecular genetic alterations: high-grade serous and possibly endometrioid carcinomas most … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

9
264
0
17

Year Published

2006
2006
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 340 publications
(290 citation statements)
references
References 122 publications
9
264
0
17
Order By: Relevance
“…Therefore, we are not going to comment these partially conflicting results and refer the reader to some recent excellent reviews on B-RAF mutations in general 6,86,103 and on overviews focusing on B-RAF and melanoma, 104,105 thyroid 106,107 or ovarian cancer. 108 Another rising field of research is to investigate how the immune system deals with B-RAF mutations, or in other words, whether mutated B-RAF is targeted by immune surveillance. 109 The immunogenicity of constitutively active V600E B-RAF was successfully demonstrated by the detection of CD8 + responses, which were either HLA-B*2705-restricted 110 or HLA-A*0201-restricted 111 and of a V600E B-RAF specific CD4 1 T-cell response.…”
Section: Raf Kinases and Human Cancermentioning
confidence: 99%
“…Therefore, we are not going to comment these partially conflicting results and refer the reader to some recent excellent reviews on B-RAF mutations in general 6,86,103 and on overviews focusing on B-RAF and melanoma, 104,105 thyroid 106,107 or ovarian cancer. 108 Another rising field of research is to investigate how the immune system deals with B-RAF mutations, or in other words, whether mutated B-RAF is targeted by immune surveillance. 109 The immunogenicity of constitutively active V600E B-RAF was successfully demonstrated by the detection of CD8 + responses, which were either HLA-B*2705-restricted 110 or HLA-A*0201-restricted 111 and of a V600E B-RAF specific CD4 1 T-cell response.…”
Section: Raf Kinases and Human Cancermentioning
confidence: 99%
“…b-catenin gene mutations are common molecular alterations in endometrioid carcinomas and therefore have emerged as a promising prognostic marker of this tumor. [11][12][13][14][15] b-Catenin has been implicated in two important biological processes: cell-cell adhesion and signal transduction. 16 In adherens junctions of epithelial cells, b-catenin association with the cytoplasmic domain of cadherins has an important function in Ca 2 þ -dependent cell adhesion.…”
mentioning
confidence: 99%
“…Compared to the serous surface epithelial subtype (serous adenocarcinoma, SAC), which comprises the majority of EOC, some types such as CCC and endometrioid adenocarcinoma (EAC) have been associated with endometriosis (6). CCC are most frequently associated with ovarian and/or pelvic endometriosis in Japan (5).…”
Section: Introductionmentioning
confidence: 99%